KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism. / Vaseva, Angelina V; Blake, Devon R; Gilbert, Thomas S K; Ng, Serina; Hostetter, Galen; Azam, Salma H; Ozkan-Dagliyan, Irem; Gautam, Prson; Bryant, Kirsten L; Pearce, Kenneth H; Herring, Laura E; Han, Haiyong; Graves, Lee M; Witkiewicz, Agnieszka K; Knudsen, Erik S; Pecot, Chad V; Rashid, Naim; Houghton, Peter J; Wennerberg, Krister; Cox, Adrienne D; Der, Channing J.

I: Cancer Cell, Bind 34, Nr. 5, 2018, s. 807-822.e1-e7.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Vaseva, AV, Blake, DR, Gilbert, TSK, Ng, S, Hostetter, G, Azam, SH, Ozkan-Dagliyan, I, Gautam, P, Bryant, KL, Pearce, KH, Herring, LE, Han, H, Graves, LM, Witkiewicz, AK, Knudsen, ES, Pecot, CV, Rashid, N, Houghton, PJ, Wennerberg, K, Cox, AD & Der, CJ 2018, 'KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism', Cancer Cell, bind 34, nr. 5, s. 807-822.e1-e7. https://doi.org/10.1016/j.ccell.2018.10.001

APA

Vaseva, A. V., Blake, D. R., Gilbert, T. S. K., Ng, S., Hostetter, G., Azam, S. H., Ozkan-Dagliyan, I., Gautam, P., Bryant, K. L., Pearce, K. H., Herring, L. E., Han, H., Graves, L. M., Witkiewicz, A. K., Knudsen, E. S., Pecot, C. V., Rashid, N., Houghton, P. J., Wennerberg, K., ... Der, C. J. (2018). KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism. Cancer Cell, 34(5), 807-822.e1-e7. https://doi.org/10.1016/j.ccell.2018.10.001

Vancouver

Vaseva AV, Blake DR, Gilbert TSK, Ng S, Hostetter G, Azam SH o.a. KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism. Cancer Cell. 2018;34(5):807-822.e1-e7. https://doi.org/10.1016/j.ccell.2018.10.001

Author

Vaseva, Angelina V ; Blake, Devon R ; Gilbert, Thomas S K ; Ng, Serina ; Hostetter, Galen ; Azam, Salma H ; Ozkan-Dagliyan, Irem ; Gautam, Prson ; Bryant, Kirsten L ; Pearce, Kenneth H ; Herring, Laura E ; Han, Haiyong ; Graves, Lee M ; Witkiewicz, Agnieszka K ; Knudsen, Erik S ; Pecot, Chad V ; Rashid, Naim ; Houghton, Peter J ; Wennerberg, Krister ; Cox, Adrienne D ; Der, Channing J. / KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism. I: Cancer Cell. 2018 ; Bind 34, Nr. 5. s. 807-822.e1-e7.

Bibtex

@article{d3a3d84648c54a9088dc1c2823a8af94,

title = "KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism",

abstract = "Our recent ERK1/2 inhibitor analyses in pancreatic ductal adenocarcinoma (PDAC) indicated ERK1/2-independent mechanisms maintaining MYC protein stability. To identify these mechanisms, we determined the signaling networks by which mutant KRAS regulates MYC. Acute KRAS suppression caused rapid proteasome-dependent loss of MYC protein, through both ERK1/2-dependent and -independent mechanisms. Surprisingly, MYC degradation was independent of PI3K-AKT-GSK3β signaling and the E3 ligase FBWX7. We then established and applied a high-throughput screen for MYC protein degradation and performed a kinome-wide proteomics screen. We identified an ERK1/2-inhibition-induced feedforward mechanism dependent on EGFR and SRC, leading to ERK5 activation and phosphorylation of MYC at S62, preventing degradation. Concurrent inhibition of ERK1/2 and ERK5 disrupted this mechanism, synergistically causing loss of MYC and suppressing PDAC growth.",

author = "Vaseva, {Angelina V} and Blake, {Devon R} and Gilbert, {Thomas S K} and Serina Ng and Galen Hostetter and Azam, {Salma H} and Irem Ozkan-Dagliyan and Prson Gautam and Bryant, {Kirsten L} and Pearce, {Kenneth H} and Herring, {Laura E} and Haiyong Han and Graves, {Lee M} and Witkiewicz, {Agnieszka K} and Knudsen, {Erik S} and Pecot, {Chad V} and Naim Rashid and Houghton, {Peter J} and Krister Wennerberg and Cox, {Adrienne D} and Der, {Channing J}",

year = "2018",

doi = "10.1016/j.ccell.2018.10.001",

language = "English",

volume = "34",

pages = "807--822.e1--e7",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "5",

}

RIS

TY - JOUR

T1 - KRAS Suppression-Induced Degradation of MYC Is Antagonized by a MEK5-ERK5 Compensatory Mechanism

AU - Vaseva, Angelina V

AU - Blake, Devon R

AU - Gilbert, Thomas S K

AU - Ng, Serina

AU - Hostetter, Galen

AU - Azam, Salma H

AU - Ozkan-Dagliyan, Irem

AU - Gautam, Prson

AU - Bryant, Kirsten L

AU - Pearce, Kenneth H

AU - Herring, Laura E

AU - Han, Haiyong

AU - Graves, Lee M

AU - Witkiewicz, Agnieszka K

AU - Knudsen, Erik S

AU - Pecot, Chad V

AU - Rashid, Naim

AU - Houghton, Peter J

AU - Wennerberg, Krister

AU - Cox, Adrienne D

AU - Der, Channing J

PY - 2018

Y1 - 2018

N2 - Our recent ERK1/2 inhibitor analyses in pancreatic ductal adenocarcinoma (PDAC) indicated ERK1/2-independent mechanisms maintaining MYC protein stability. To identify these mechanisms, we determined the signaling networks by which mutant KRAS regulates MYC. Acute KRAS suppression caused rapid proteasome-dependent loss of MYC protein, through both ERK1/2-dependent and -independent mechanisms. Surprisingly, MYC degradation was independent of PI3K-AKT-GSK3β signaling and the E3 ligase FBWX7. We then established and applied a high-throughput screen for MYC protein degradation and performed a kinome-wide proteomics screen. We identified an ERK1/2-inhibition-induced feedforward mechanism dependent on EGFR and SRC, leading to ERK5 activation and phosphorylation of MYC at S62, preventing degradation. Concurrent inhibition of ERK1/2 and ERK5 disrupted this mechanism, synergistically causing loss of MYC and suppressing PDAC growth.

AB - Our recent ERK1/2 inhibitor analyses in pancreatic ductal adenocarcinoma (PDAC) indicated ERK1/2-independent mechanisms maintaining MYC protein stability. To identify these mechanisms, we determined the signaling networks by which mutant KRAS regulates MYC. Acute KRAS suppression caused rapid proteasome-dependent loss of MYC protein, through both ERK1/2-dependent and -independent mechanisms. Surprisingly, MYC degradation was independent of PI3K-AKT-GSK3β signaling and the E3 ligase FBWX7. We then established and applied a high-throughput screen for MYC protein degradation and performed a kinome-wide proteomics screen. We identified an ERK1/2-inhibition-induced feedforward mechanism dependent on EGFR and SRC, leading to ERK5 activation and phosphorylation of MYC at S62, preventing degradation. Concurrent inhibition of ERK1/2 and ERK5 disrupted this mechanism, synergistically causing loss of MYC and suppressing PDAC growth.

U2 - 10.1016/j.ccell.2018.10.001

DO - 10.1016/j.ccell.2018.10.001

M3 - Journal article

C2 - 30423298

VL - 34

SP - 807-822.e1-e7

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 5

ER -

ID: 215091591